Fate of the pancreas after asynchronous kidney loss in patients undergoing simultaneous kidney/pancreas transplantation.
University of Nebraska Medical Center and NHS Clarkson Hospital, Omaha, Nebraska, USA.
S
S
Chinnakotla
R J
RJ
Taylor
A
A
DeRoover
R J
RJ
Stratta
J P
JP
Leone
D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage; D002908:Chronic Disease; D016572:Cyclosporine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D016035:Pancreas Transplantation / Q000502:physiology*; D006435:Renal Dialysis; D012086:Reoperation; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine